EP3400943

ARRAY BIOPHARMA, INC.
Application Number
EP18162971A
Filing Date
Mar 25, 2013
Status
Granted And Under Opposition
Oct 30, 2020
Grant Date
Dec 2, 2020
External Links
Slate, Register

Biblio Summary

The patent EP3400943B1 was granted on Dec 2, 2020 by Array Biopharma, Inc. The patent is currently Granted And Under Opposition.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZSep 1, 2021ADMISSIBLE
TEVASep 1, 2021ADMISSIBLE

The table below shows the patents of Array Biopharma, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3702351Formulation Comprising A Mek InhibitorNov 22, 20232
EP3000810N3 Alkylated Benzimidazole Derivative As Mek InhibitorJul 19, 20171